Av Block clinical trials

Explore recruiting av block clinical trials.

Recruiting av block studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Av Block trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Impact of beta blocker administration on outcome among patients undergoing transcatheter aortic valve replacement - B-TAVR

Austria, Germany

Therapeutic use (Phase IV) EU CTIS Study details

A phase II, multicenter, 1:1 randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy of bolus application of Cyclosporine A (CsA) or Placebo in patients with Takotsubo syndrome. (Cyclosporine In Takotsubo syndrome (CIT))

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Single-blinded randomized investigator-initiated controlled trial to assess the efficacy of colchicine to treat patients with cardiomyopathy with myocarditis (chronic inflammatory cardiomyopathy) – Trial and Registry to study the role of genotype environment interaction in Chronic myocarditis and inflammatory cardiomyopathies with ventricular pro-arrhythmic and heart failure phenotypes (PNRR-MAD-2022-12376225)

Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

Single blind randomized controlled trial to assess the safety and efficacy of high dose pulse intravenous corticosteroid therapy to treat patients with complicated/fulminant acute myocarditis

Italy, Belgium, Spain, Austria, Czechia, Finland +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

The effect of early Landiolol in patients with ST-elevation acute coronary syndrome undergoing primary percutaneous coronary intervention – A prospective, randomized, double- blinded, placebo controlled, phase IV pilot trial (STEMILAND-1)

Austria

Therapeutic use (Phase IV) EU CTIS Study details

Single-blind, investigator-initiated, randomized, controlled trial to assess the safety and efficacy of intravenous corticosteroid therapy to treat patients with acute myocarditis with mildly reduced left ventricular ejection fraction

Belgium, Italy, Slovenia, Spain

Phase III and phase IV (Integrated) EU CTIS Study details

Av Block trials by city

Av Block in Toronto Av Block in Vancouver Av Block in Montreal Av Block in Calgary Av Block in Edmonton Av Block in Ottawa Av Block in Winnipeg Av Block in Quebec City Av Block in Hamilton Av Block in Kitchener Av Block in London Av Block in Halifax Av Block in New York Av Block in Los Angeles Av Block in Chicago Av Block in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease